AI Article Synopsis
- Patients have been overexposed to imaging-related radiation, prompting radiology and medical physics communities to find ways to reduce radiation while still capturing high-quality diagnostic images.
- Innovative methods include optimizing CT scanning parameters, developing new scanning protocols, and using advanced dose reduction technologies.
- A major challenge in effectively reducing radiation doses, especially in abdominal and pelvic imaging, is the variation in patient size, which affects exposure levels.
Article Abstract
Reported instances of patients' overexposure to imaging-related radiation have spurred the radiology and medical physics communities to identify and develop methods for decreasing the amount of radiation used to achieve diagnostic-quality images. These initiatives include examining and optimizing conventional CT scanning parameters, introducing innovative scan protocols, and incorporating novel dose reduction technologies. The greatest challenge to effective dose reduction in the abdomen and pelvis remains patient size. Here, we review the state of the art in abdominopelvic CT in both adult and pediatric patients and describe some of our own efforts in dose reduction for these types of examinations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00261-013-0028-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prophylaxis of HBV reinfection and disease in liver transplanted patients: 2024 update on the role of HBIG and cost-effectiveness evaluation.
Minerva Gastroenterol (Torino)
January 2025
Gastroenterology Department of Emergency and Organ Transplantation, University Hospital Policlinico di Bari, Bari, Italy.
Hepatitis B virus (HBV) infection is a major global health concern, with liver transplantation (LT) serving as a critical treatment for end-stage liver disease caused by HBV. However, the risk of HBV reinfection after LT remains significant, necessitating effective prophylaxis. Today, the combination of hepatitis B immune globulin (HBIG) and high-barrier nucleos(t)ide analogues (NUCs) is the standard of care for preventing HBV recurrence post-LT but concerns about the cost of HBIG and access to high-barrier NUCs have led to a reduction in the use, dose, and duration of HBIG in recent years.
View Article and Find Full Text PDFCost-effective evaluation of modified ochre soil and its combination with cationic polyacrylamide for municipal wastewater sludge conditioning.
Water Sci Technol
January 2025
Department of Chemical Engineering, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.
One of the most costly stages of activated sludge wastewater treatment plants is the treatment and dewatering of waste sludge. Chemical conditioning of sludge, as one of the most widespread methods to enhance sludge dewaterability, accounts for a significant portion of operational expenses due to the consumption of expensive polymeric compounds. This research aims to assess the cost-effectiveness of ochre soil, modified with hydrochloric acid, as an affordable mineral for conditioning waste sludge in an activated sludge system.
View Article and Find Full Text PDFEculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety - a single-center study.
Hematology
December 2025
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Objective: To evaluate the short-term efficacy and safety of eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in China.
Method: Data were retrospectively collected from patients with PNH who received at least 3 months of full-dose eculizumab. Changes in clinical and laboratory indicators after 1, 3, and 6 months of eculizumab therapy and at the end of follow-up were documented.
Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
J Pain Res
January 2025
Department of Orthopedics, Sri Ram Ortho and Physio Rehab Centre, Varanasi, Uttar Pradesh, 221007, India.
Purpose: Turmeric extract is a well-known nutraceutical ingredient recognized for its benefits in managing musculoskeletal health. This study evaluated the efficacy and safety of a novel low-dose water-dispersible turmeric extract containing 60% natural curcuminoids (WDTE60N) in participants with mild-to-moderate knee osteoarthritis.
Patients And Methods: This double-blind, randomized, placebo-controlled trial was conducted at two orthopedic centers in Uttar Pradesh, India (July 2023-November 2023).
Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer.
Int J Breast Cancer
January 2025
Department of Hematology and Oncology, Houston Methodist Dr Mary and Ron Neal Cancer Center, Houston, Texas, USA.
This study evaluates the effects of hydroxytyrosol (HT), a component of olive oil, on mammographic breast density reduction. We explored effects of HT on Wnt -catenin and other pathways involved in cancer stem cell renewal, DNA repair, cell proliferation, and differentiation. Twenty-five milligrams per day oral dose of HT was given for 12 months in pre- and postmenopausal women at increased risk of breast cancer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!